JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Insmed
INSM
$28.6B
| $51.7M | 0.01% |
2,115,370
+49,581
| +2% | +$1.13M |
|
852
Herbalife
HLF
$1.29B
| $51.7M | 0.01% |
1,875,286
+108,468
| +6% | +$2.63M |
|
|
COR
853
DELISTED
Coresite Realty Corporation
COR
| $51.4M | 0.01% |
1,131,875
+20,800
| +2% | +$992K |
|
854
CALL
McDonald's
MCD
$195B
| $51.3M | 0.01% |
539,400
+162,500
| +43% | +$15.7M |
|
|
EXL
855
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $51.2M | 0.01% |
3,244,403
-25,830
| -0.8% | -$406K |
|
856
Minerals Technologies
MTX
$2.34B
| $50.6M | 0.01% |
742,176
+6,555
| +0.9% | +$455K |
|
857
Wynn Resorts
WYNN
$10.6B
| $50.3M | 0.01% |
509,535
+107,431
| +27% | +$12.1M |
|
858
Conagra Brands
CAG
$7.23B
| $50.1M | 0.01% |
1,472,051
-240,511
| -14% | -$7.22M |
|
859
Papa John's
PZZA
$806M
| $50M | 0.01% |
661,754
-74,857
| -10% | -$5M |
|
860
PUT
Matador Resources
MTDR
$6.09B
| $50M | 0.01% |
2,000,000
+1,873,000
| +1,475% | +$50.2M |
|
|
AEL
861
DELISTED
American Equity Investment Life Holding Company
AEL
| $49.8M | 0.01% |
1,847,223
-37,536
| -2% | -$1.03M |
|
862
MillerKnoll
MLKN
$1.67B
| $49.6M | 0.01% |
1,714,918
+2,897
| +0.2% | +$82.5K |
|
863
Unisys
UIS
$217M
| $49.6M | 0.01% |
2,481,367
+381,649
| +18% | +$8.21M |
|
864
Western Alliance Bancorporation
WAL
$8.87B
| $49.5M | 0.01% |
1,466,201
-142,871
| -9% | -$4.56M |
|
|
AGN.PRA
865
DELISTED
Allergan plc
AGN.PRA
| $49.2M | 0.01% |
+47,042
| New | +$49.2M |
|
866
NGL Energy Partners
NGL
$2.11B
| $49M | 0.01% |
1,617,109
-135,500
| -8% | -$3.99M |
|
867
Aon
AON
$76B
| $49M | 0.01% |
491,635
-4,730,635
| -91% | -$473M |
|
|
PFPT
868
DELISTED
Proofpoint, Inc.
PFPT
| $49M | 0.01% |
769,460
-10,656
| -1% | -$627K |
|
|
GRFS
869
Grifois
GRFS
$5.4B
| $48.8M | 0.01% |
3,153,756
+947,762
| +43% | +$15.4M |
|
|
MEG
870
DELISTED
Media General, Inc
MEG
| $48.7M | 0.01% |
2,946,072
+2,613,143
| +785% | +$43.4M |
|
|
CMRX
871
DELISTED
Chimerix, Inc.
CMRX
| $48.6M | 0.01% |
1,052,153
-236,390
| -18% | -$9.48M |
|
|
P
872
DELISTED
Pandora Media Inc
P
| $48.5M | 0.01% |
3,119,418
+2,074,054
| +198% | +$36.4M |
|
873
Acadia Pharmaceuticals
ACAD
$5.03B
| $48.4M | 0.01% |
1,155,244
-204,444
| -15% | -$7.91M |
|
874
Factset
FDS
$10.2B
| $48.4M | 0.01% |
297,653
-15,504
| -5% | -$2.52M |
|
|
PF
875
DELISTED
Pinnacle Foods, Inc.
PF
| $48.2M | 0.01% |
1,059,446
+115,151
| +12% | +$4.87M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.